BCAB Financial Statements

Balance sheet, income statement, cash flow, and dividends for Bioatla Inc (BCAB).


$28.58M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

BCAB Market Cap. (MRY)


BCAB Shares Outstanding (MRY)


BCAB Assets (MRY)


Total Assets

$52.42M

Total Liabilities

$38.16M

Total Investments

$0

BCAB Income (MRY)


Revenue

$11.00M

Net Income

-$69.78M

Operating Expense

$84.94M

BCAB Cash Flow (MRY)


CF Operations

-$71.94M

CF Investing

$0

CF Financing

$9.51M

BCAB Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

BCAB Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$52,422,000 (-56.19%)

$119,658,000 (-46.99%)

$225,736,000 (-11.27%)

$254,422,000 (3.87%)

Assets Current

$51,232,000 (-55.99%)

$116,406,000 (-47.19%)

$220,431,000 (-10.86%)

$247,292,000 (2.75%)

Assets Non-Current

$1,190,000 (-63.41%)

$3,252,000 (-38.70%)

$5,305,000 (-25.60%)

$7,130,000 (67.53%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$14,265,000 (-79.82%)

$70,672,000 (-60.81%)

$180,339,000 (-14.46%)

$210,821,000 (0.40%)

Property Plant & Equipment Net

$1,190,000 (-61.59%)

$3,098,000 (-39.86%)

$5,151,000 (-26.16%)

$6,976,000 (70.06%)

Cash & Equivalents

$49,046,000 (-56.00%)

$111,471,000 (-48.27%)

$215,507,000 (-12.03%)

$244,979,000 (2.67%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$13,704,000 (-48.71%)

$26,720,000 (23.65%)

$21,610,000 (17.29%)

$18,424,000 (52.67%)

Accumulated Retained Earnings (Deficit)

-$486,039,000 (-16.76%)

-$416,263,000 (-42.17%)

-$292,801,000 (-57.15%)

-$186,319,000 (-104.93%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$836,000 (-66.02%)

$2,460,000 (-38.21%)

$3,981,000 (-25.88%)

$5,371,000 (687.54%)

Debt Current

$836,000 (-48.52%)

$1,624,000 (6.77%)

$1,521,000 (9.50%)

$1,389,000 (0%)

Debt Non-Current

$0 (0%)

$836,000 (-66.02%)

$2,460,000 (-38.22%)

$3,982,000 (483.87%)

Total Liabilities

$38,157,000 (-22.11%)

$48,986,000 (7.91%)

$45,397,000 (4.12%)

$43,601,000 (24.71%)

Liabilities Current

$14,540,000 (-48.70%)

$28,344,000 (22.54%)

$23,131,000 (16.75%)

$19,813,000 (-38.59%)

Liabilities Non-Current

$23,617,000 (14.41%)

$20,642,000 (-7.29%)

$22,266,000 (-6.40%)

$23,788,000 (780.38%)

BCAB Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$11,000,000 (0%)

$0 (0%)

$0 (0%)

$250,000 (-41.72%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$21,848,000 (-15.83%)

$25,956,000 (-9.85%)

$28,793,000 (-25.05%)

$38,416,000 (262.59%)

Research & Development Expense

$63,095,000 (-39.17%)

$103,731,000 (30.73%)

$79,347,000 (36.16%)

$58,274,000 (192.35%)

Operating Expenses

$84,943,000 (-34.50%)

$129,687,000 (19.93%)

$108,140,000 (11.84%)

$96,690,000 (216.73%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$3,000 (-99.78%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$69,776,000 (43.48%)

-$123,462,000 (-15.95%)

-$106,482,000 (-11.61%)

-$95,402,000 (-166.09%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$69,776,000 (43.48%)

-$123,462,000 (-15.95%)

-$106,482,000 (-11.61%)

-$95,402,000 (-166.09%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$69,776,000 (43.48%)

-$123,462,000 (-15.95%)

-$106,482,000 (-11.61%)

-$95,402,000 (-166.09%)

Weighted Average Shares

$48,573,364 (1.67%)

$47,777,568 (22.74%)

$38,927,268 (12.63%)

$34,561,245 (310.07%)

Weighted Average Shares Diluted

$48,573,364 (1.67%)

$47,777,568 (22.74%)

$38,927,268 (12.63%)

$34,561,245 (310.07%)

Earning Before Interest & Taxes (EBIT)

-$69,776,000 (43.48%)

-$123,462,000 (-15.95%)

-$106,482,000 (-11.62%)

-$95,399,000 (-176.81%)

Gross Profit

$11,000,000 (0%)

$0 (0%)

$0 (0%)

$250,000 (-41.72%)

Operating Income

-$73,943,000 (42.98%)

-$129,687,000 (-19.93%)

-$108,140,000 (-12.13%)

-$96,440,000 (-220.41%)

BCAB Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

-$98,000 (63.02%)

-$265,000 (71.32%)

-$924,000 (-56.61%)

Net Cash Flow from Financing

$9,511,000 (12251.95%)

$77,000 (-99.87%)

$61,213,000 (-11.94%)

$69,512,000 (-74.43%)

Net Cash Flow from Operations

-$71,936,000 (30.84%)

-$104,015,000 (-15.04%)

-$90,420,000 (-45.34%)

-$62,214,000 (-71.23%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$62,425,000 (40.00%)

-$104,036,000 (-253.00%)

-$29,472,000 (-562.38%)

$6,374,000 (-97.29%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

-$98,000 (63.02%)

-$265,000 (71.32%)

-$924,000 (-56.61%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$9,557,000 (2744.35%)

$336,000 (-99.46%)

$61,971,000 (-10.85%)

$69,512,000 (-65.28%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$8,921,000 (-34.13%)

$13,544,000 (-7.00%)

$14,563,000 (-42.02%)

$25,117,000 (731.14%)

Depreciation Amortization & Accretion

$925,000 (-24.24%)

$1,221,000 (1.83%)

$1,199,000 (-9.85%)

$1,330,000 (31.94%)

BCAB Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00%

-

-

100.00% (0.00%)

Profit Margin

-634.30%

-

-

-38160.80% (-356.62%)

EBITDA Margin

-625.90%

-

-

-37627.60% (-382.49%)

Return on Average Equity (ROAE)

-235.90% (-113.29%)

-110.60% (-76.11%)

-62.80% (-34.19%)

-46.80% (-0.43%)

Return on Average Assets (ROAA)

-102.40% (-35.81%)

-75.40% (-52.02%)

-49.60% (-27.18%)

-39.00% (-38.30%)

Return on Sales (ROS)

-634.30%

-

-

-38159.60% (-375.00%)

Return on Invested Capital (ROIC)

690.60% (-1.23%)

699.20% (-54.16%)

1525.30% (263.34%)

419.80% (71.84%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.41 (56.87%)

-0.95 (68.35%)

-3.01 (57.66%)

-7.11 (33.29%)

Price to Sales Ratio (P/S)

2.61

-

-

2,713.75 (306.15%)

Price to Book Ratio (P/B)

2 (20.07%)

1.67 (-2.97%)

1.72 (-49.85%)

3.43 (-31.66%)

Debt to Equity Ratio (D/E)

2.67 (286.00%)

0.69 (175.00%)

0.25 (21.74%)

0.21 (23.95%)

Earnings Per Share (EPS)

-1.44 (44.19%)

-2.58 (5.84%)

-2.74 (0.72%)

-2.76 (13.48%)

Sales Per Share (SPS)

0.23 (0%)

0 (0%)

0 (0%)

0.01 (-86.27%)

Free Cash Flow Per Share (FCFPS)

-1.48 (32.03%)

-2.18 (6.48%)

-2.33 (-27.53%)

-1.83 (58.30%)

Book Value Per Share (BVPS)

0.29 (-80.12%)

1.48 (-68.08%)

4.63 (-24.05%)

6.1 (-75.51%)

Tangible Assets Book Value Per Share (TABVPS)

1.08 (-56.91%)

2.5 (-56.82%)

5.8 (-21.22%)

7.36 (-74.67%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-1 (80.00%)

-5 (82.76%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.39 (130.95%)

0.17 (112.96%)

-1.3 (73.10%)

-4.82 (83.85%)

Asset Turnover

0.16 (0%)

0 (0%)

0 (0%)

0 (-66.67%)

Current Ratio

3.52 (-14.20%)

4.11 (-56.90%)

9.53 (-23.64%)

12.48 (67.31%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$71,936,000 (30.91%)

-$104,113,000 (-14.81%)

-$90,685,000 (-43.63%)

-$63,138,000 (-70.99%)

Enterprise Value (EV)

-$26,683,097 (-30.08%)

-$20,512,912 (-115.03%)

$136,485,200 (-69.88%)

$453,162,716 (-54.59%)

Earnings Before Tax (EBT)

-$69,776,000 (43.48%)

-$123,462,000 (-15.95%)

-$106,482,000 (-11.61%)

-$95,402,000 (-166.09%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$68,851,000 (43.68%)

-$122,241,000 (-16.11%)

-$105,283,000 (-11.92%)

-$94,069,000 (-181.17%)

Invested Capital

-$10,328,000 (41.64%)

-$17,697,000 (-98.37%)

-$8,921,000 (-78.46%)

-$4,999,000 (80.20%)

Working Capital

$36,692,000 (-58.33%)

$88,062,000 (-55.37%)

$197,300,000 (-13.27%)

$227,479,000 (9.14%)

Tangible Asset Value

$52,422,000 (-56.19%)

$119,658,000 (-46.99%)

$225,736,000 (-11.27%)

$254,422,000 (3.87%)

Market Capitalization

$28,581,903 (-75.76%)

$117,922,088 (-61.99%)

$310,260,200 (-57.09%)

$723,087,716 (-31.39%)

Average Equity

$29,579,750 (-73.49%)

$111,579,500 (-34.17%)

$169,494,500 (-16.85%)

$203,853,250 (164.73%)

Average Assets

$68,123,250 (-58.41%)

$163,802,250 (-23.72%)

$214,749,250 (-12.15%)

$244,449,000 (92.27%)

Invested Capital Average

-$10,103,000 (42.79%)

-$17,658,250 (-152.94%)

-$6,981,250 (69.28%)

-$22,726,750 (-61.11%)

Shares

48,345,573 (0.85%)

47,935,808 (27.46%)

37,607,297 (2.09%)

36,835,849 (18.87%)